ANIP - CIK 0001023024
ANI PHARMACEUTICALS INC trades as ANIP and has a market capitalization of $1.84 B, making it the #2168 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $883.37M, up 43.8% from the prior year and net income of $78.00M. This page tracks ANI PHARMACEUTICALS INC through 1,742 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years ANI PHARMACEUTICALS INC's revenue grew from $128.62M to $883.37M, a compound annual growth rate of 23.9%. Net profit margin expanded from 3.1% to 8.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-year
Record quarterly and full year net revenues of $247.1 million and $883.4 million, up 29.6% and 43.8% year-over-year, respectively
Record quarterly net revenues of $227.8 million, an increase of 53.6% year-over-year
Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basis
The largest companies sharing ANI PHARMACEUTICALS INC's SEC industry classification (pharmaceutical preparations).
ANI PHARMACEUTICALS INC (ANIP) has a market capitalization of $1.84 B as of 2026-06-10, ranking #2168 among US-listed companies.
ANI PHARMACEUTICALS INC reported revenue of $883.37M for fiscal year 2025, an increase of 43.8% year over year.
Yes. ANI PHARMACEUTICALS INC reported net income of $78.00M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4%